Turning Point Stock Doubles ntawm Bristol Deal. Nws txhais li cas rau Biotech M&A.

Ntawv loj

Turning Point Therapeutics

Tshuag tau ntau dua ob npaug tom qab

Bristol Myers

Squibb tshaj tawm tias nws tau pom zoo yuav lub tuam txhab. Nws tsuas yog qhov kev cog lus tshiab tshaj plaws rau cov khoom lag luam biotech uas raug ntaus.

Turning Point stock (TPTX) tau nce 114% rau $ 73.26 thaum 7:05 teev sawv ntxov hnub Friday tom qab Bristol (BMY) tau hais tias nws yuav yuav lub tuam txhab me me biotech rau $ 76 ib feem. Bristol Tshuag tau hloov me ntsis.

Turning Point tsis muaj cov khoom muag tam sim no, tab sis muaj cov tshuaj kho mob ntsws cancer hauv kev sim tshuaj, thiab ua haujlwm rau lwm yam kev kho mob qog noj ntshav. Pom tau tias, Bristol xav tias zoo txaus txog cov kev kho mob no-thiab cov thev naus laus zis tom qab-kom them nyiaj rau lub tuam txhab.

"Kev nrhiav tau ntawm Turning Point Therapeutics txuas ntxiv nthuav dav peb cov thawj coj ntawm oncology franchise los ntawm kev ntxiv qhov zoo tshaj plaws-hauv-chav kawm, lig-theem precision oncology cuab tam," Bristol CEO Giovanni Caforio said nyob rau hauv ib daim ntawv qhia. "Nrog rau qhov kev hloov pauv no, peb tab tom txuas ntxiv peb cov ntaub ntawv muaj zog ntawm kev txhim kho kev lag luam txhawm rau txhim kho peb txoj kev loj hlob ntxiv."

mas m&a news

• Kohl's Offers Qhia Scars ntawm Cov Khw Muag Khoom

Qhov kev pom zoo tsuas yog qhov tseeb hauv qhov chaw biotech.

Pfizer

(PFE) tshaj tawm tus tshaaj ntawm Biohaven (BHVN) rau $ 11 nphom thaum lub Tsib Hlis 10, thaum

GlaxoSmithKline

(GSK) hais tias nws yuav yuav

Sierra Oncology

(SRRA) rau $ 1.9 nphom hauv lub Plaub Hlis. "BMY / TPTX coj Biotech-rau-public-rau-public M&A suav rau 7 YTD thiab $ 21.3B hauv tus nqi duas, yog li peb txhua xyoo rau 17 takeouts thiab $ 50.7B hauv duas tus nqi rau 2022 uas yog qis dua 2021's 17 takeouts rau $ 61B hauv tus nqi duas," sau Jefferies 'Will Sevush.

Thiab cov lej no tseem tsawg dhau los ua kev pab ntau rau biotech stocks. tus

SPDR S&P Biotech ETF
(XBI) tau poob 39% xyoo no, thiab tsuas yog nce 0.4% lub lim tiam dhau los txawm tias

SPDR S&P 500 ETF
(SPY) tau nce 3%. Turning Point Tshuag tau poob 28% txog rau hnub Thursday kaw.

Bristol Myers yog ib tug Barron tus khaws khoom Lub Tsib Hlis 26, hauv ib feem rau lub raj xa dej uas suav nrog ntau dua 10 qhov kev kho mob qog noj ntshav. Tam sim no nws muaj lwm yam.

Sau ntawv mus rau Ben Levisohn ntawm [email tiv thaiv]